Update shared on04 Aug 2025
Fair value Decreased 13%Huntsman's consensus price target was revised downward as profitability outlooks weakened—reflected in a sharply higher forward P/E and falling net margins—resulting in a new fair value of $12.15.
What's in the News
- Huntsman will incur a one-time non-cash asset impairment charge of approximately $75 million in the second quarter of 2025 due to the closure of its Moers, Germany facility.
- The company completed a strategic review and is closing its European Maleic Anhydride facility in Moers, Germany by quarter-end, shifting European supply to North American sites in Florida and Louisiana.
- Huntsman successfully relocated its Global Business Services center in Kraków to a new, larger office optimized for growth, team collaboration, and workplace flexibility.
Valuation Changes
Summary of Valuation Changes for Huntsman
- The Consensus Analyst Price Target has fallen from $12.96 to $12.15.
- The Future P/E for Huntsman has significantly risen from 18.51x to 33.68x.
- The Net Profit Margin for Huntsman has significantly fallen from 2.48% to 1.30%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.